Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Mallinckrodt and SmithKline Beecham sign copromotion agreement for ADHD drug

July 12, 1999

FDA advisory committee to consider OTC status for Flexeril

July 9, 1999

Abaperidone undergoes extensive efficacy and safety testing at Ferrer

July 9, 1999

New nitrone derivative protects against oxidative stress-induced damage

July 9, 1999

Potential new spinal analgesic --MPV-2426-- characterized at Orion

July 9, 1999

Citicoline combination treatment shows synergistic effect in reducing stroke infarct volume

July 9, 1999

In the news: Elan's novel approach to treatment and prevention of AD

July 9, 1999

Gruenenthal designs new analgesics

July 8, 1999

New sigma-receptor ligands claimed by Mitsubishi for CNS, GI and cardiovascular disorders

July 8, 1999

Health Canada approves Betaseron for treatment of SPMS

July 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...